This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Yves Durocher, PhD
Section Head, Mammalian Cell Expression - NRC Human Health Therapeutics Research Center at National Research Council Canada


Yves Durocher obtained his PhD in Biochemistry at the Université de Montréal in 1993. He joined the NRC in 1995 and was in charge of industrial projects with bio/pharmaceutical companies for the production of membrane receptors and recombinant proteins for various drug discovery projects. Yves manages a section of 33 members involved in protein expression and CHO cell line development for internal projects and external clients. His research activities focus on improving large-scale transient gene expression (LSTGE) platforms using HEK293 and CHO cells for protein production and on developing and engineering a stable CHO pool and clonal cell line platform for recombinant protein manufacturing. Yves is also an adjunct professor at the Department of Biochemistry and Molecular Medicine at the University of Montreal.

Agenda Sessions

  • Rapid development of trimeric SARS-CoV-2 spike-based vaccine candidates using stable CHO pools